Geriatric syndromes: How to treat
- PMID: 27540686
- PMCID: PMC5538337
- DOI: 10.1080/21505594.2016.1219445
Geriatric syndromes: How to treat
Abstract
The survival of HIV-infected persons has been increasing over the last years, thanks to the implementation of more effective pharmacological and non-pharmacological interventions. Nevertheless, HIV-infected persons are often "biologically" older than their "chronological" age due to multiple clinical, social, and behavioral conditions of risk. The detection in this population of specific biological features and syndromic conditions typical of advanced age has made the HIV infection an interesting research model of accelerated and accentuated aging. Given such commonalities, it is possible that "biologically aged" HIV-positive persons might benefit from models of adapted and integrated care developed over the years by geriatricians for the management of their frail and complex patients. In this article, possible strategies to face the increasingly prevalent geriatric syndromes in HIV-infected persons are discussed. In particular, it is explained the importance of shifting from the traditional disease-oriented approach into models of care facilitating a multidisciplinary management of frailty.
Keywords: HIV; elderly; frailty; geriatrics; integrated care; prevention.
References
-
- World report on ageing and health. World Health Organization: Geneva, Switzerland, 2015; pp. 89-123.
-
- Tinetti ME, Fried T. The end of the disease era. Am J Med 2004; 116:179-85; PMID:14749162; https://doi.org/10.1016/j.amjmed.2003.09.031 - DOI - PubMed
-
- Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, et al.. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013; 8:e81355; PMID:24367482; https://doi.org/10.1371/journal.pone.0081355 - DOI - PMC - PubMed
-
- Pathai S, Bajillan H, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci 2014; 69:833-42; PMID:24158766; https://doi.org/10.1093/gerona/glt168 - DOI - PMC - PubMed
-
- Pahor M, Cesari M. Designing Phase II B trials in sarcopenia: the best target population. J Nutr Health Aging 2011; 15:725-30; PMID:21968872; https://doi.org/10.1007/s12603-011-0058-9 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical